Indian pharma hard to replace despite US tariff risk, says Systematix

Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance (IPA), said the pharma sector should be exempted from any regulation that imposes tariffs, particularly on generic medicines.